Tag Archives: ETE

Top 5 Safest Stocks To Own For 2019

Last weekend, I was driving through rural Georgia, probably faster than I should have been, listening to the Allman Brothers. It was a hot, sunny August afternoon.

—Recommended Link— Create A 10%+ Income Stream For Life
We’re sitting on a collection of the safest, most generous monthly payers available. And while $11,200 in dividend checks is a welcome addition to anyone’s income, investors also love racking up capital gains as high as 446%. Start generating a 10%+ income stream for life today from these consistent companies.

When I entered Taylor County, I started noticing something different about the farmland. For a significant stretch of the mostly deserted four-lane highway, the fields on either side weren’t planted with soybeans or cotton or peanuts or corn.

It was photovoltaic solar panels. And I’m not talking about a small cluster used to power some sort of sensor or county extension project.

Top 5 Safest Stocks To Own For 2019: CHS Inc(CHSCL)

Advisors’ Opinion:

  • [By Joseph Griffin]

    CHS (NASDAQ:CHSCL) was upgraded by analysts at BidaskClub from a “strong sell” rating to a “sell” rating in a research report issued on Friday.

Top 5 Safest Stocks To Own For 2019: Energy Transfer Equity, L.P.(ETE)

Advisors’ Opinion:

  • [By Lee Jackson]

    This MLP brings the potential for solid growth and income. Energy Transfer Equity LP (NYSE: ETE) owns the general partner and 100% of the incentive distribution rights (IDRs) of Energy Transfer Partners and Sunoco. The company also owns Lake Charles LNG. On a consolidated basis, the family of companies owns and operates a diverse portfolio of natural gas, natural gas liquids (NGLs), crude oil and refined products assets, as well as retail and wholesale motor fuel operations and liquefied natural gas terminaling.

  • [By Matthew DiLallo]

    Management teams tend to be very coy about what they’re working on behind closed doors. Energy Transfer Equity’s (NYSE:ETE) leadership, on the other hand, was very transparent about what’s going on behind the scenes during the company’s first-quarter conference call. They openly answered analysts’ questions, which provided investors with an interesting glimpse into what’s ahead.

  • [By Jon C. Ogg]

    Energy Transfer Equity L.P. (NYSE: ETE) and Energy Transfer Partners L.P. (NYSE: ETP) have entered into a definitive merger agreement for ETP to become a wholly owned subsidiary of ETE. The deal is being conducted in a unit-for-unit exchange, meaning it is a cashless merger transaction. According to the release, this transaction will act to both streamline Energy Transfer’s organizational structure and also eliminate the incentive distribution rights (IDRs) burden. ETE’s IDRs in ETP will be canceled under the transaction.

Top 5 Safest Stocks To Own For 2019: Medtronic plc(MDT)

Advisors’ Opinion:

  • [By Todd Campbell]

    Automated insulin systems like the one Eli Lilly is developing combine a monitor that continuously evaluates blood-sugar levels with a wearable pump that automatically doses insulin based on the monitor’s readings. So far, Medtronic (NYSE:MDT) and Tandem Diabetes (NASDAQ:TNDM) are the only companies that have secured FDA approval for closed-loop systems. Medtronic’s MiniMed 670G became available in 2017, and Tandem’s system is expected to become available in August 2018.

  • [By Trey Thoelcke]

    Medtronic PLC (NYSE: MDT) gets the week started with its fiscal third-quarter results first thing Tuesday morning. The consensus analyst estimates call for earnings per share (EPS) of $1.24 and $7.53 billion in revenue. Shares were changing hands at $92.27 on Friday’s close. The consensus price target is $102.10, and the 52-week trading range is $76.41 to $100.15.

  • [By Motley Fool Transcribers]

    Medtronic PLC (NYSE:MDT)Q1 2019 Earnings Conference CallAug. 21, 2018, 8:00 a.m. ET

    Contents:
    Prepared Remarks Questions and Answers Call Participants
    Prepared Remarks:

    Operator

  • [By Brian Feroldi]

    Mazor Robotics (NASDAQ:MZOR) reported its second-quarter results on Thursday. System sales volume grew but those gains were more than offset by lower selling prices related to its commercial deal with Medtronic (NYSE:MDT). The net result was that Mazor’s revenue declined by 15% when compared to the year-ago period. 

  • [By Max Byerly]

    Get a free copy of the Zacks research report on Medtronic (MDT)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Brian Feroldi]

    Here’s a review of the headline numbers from the company’s second quarter:

    Revenue for the period was $13.2 million. This figure was down 15% when compared to the year-ago period. Wall Street expected $17 million in revenue, so this was a significant miss. Management said the decline was caused by lower pricing terms due to its distribution agreement with Medtronic (NYSE:MDT). Gross margin declined 1,330 basis points to 56.1%. Operating expenses dropped 23% to $11.3 million.  Net loss was $3.8 million, or $0.07 per share. Market watchers were expecting a $0.02 loss, so this figure missed the mark, too. Cash balance at quarter end was $108 million. 

    Image source: Getty Images.

Top 5 Safest Stocks To Own For 2019: Engility Holdings, Inc.(EGL)

Advisors’ Opinion:

  • [By Shane Hupp]

    Get a free copy of the Zacks research report on Engility (EGL)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Daniel Sparks]

    The stock’s decline followed SAIC’s better-than-expected second-quarter results, as well as an announcement from SAIC that it’s acquiring Engility Holdings (NYSE:EGL), a staffing and outsourcing services company. The acquisition, which is valued at $2.5 billion when including the assumption of Engility’s $900 million in debt, is a significant undertaking given that SAIC’s total market capitalization is only around $3.5 billion.

  • [By Ethan Ryder]

    Get a free copy of the Zacks research report on Engility (EGL)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Logan Wallace]

    Get a free copy of the Zacks research report on Engility (EGL)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Stephan Byrd]

    Get a free copy of the Zacks research report on Engility (EGL)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

Top 5 Safest Stocks To Own For 2019: Nu Skin Enterprises Inc.(NUS)

Advisors’ Opinion:

  • [By Motley Fool Transcribers]

    Nu Skin Enterprises Inc  (NYSE:NUS)Q4 2018 Earnings Conference CallFeb. 13, 2019, 5:00 p.m. ET

    Contents:
    Prepared Remarks Questions and Answers Call Participants
    Prepared Remarks:

    Operator

  • [By Joseph Griffin]

    Nu Skin Enterprises, Inc. (NYSE:NUS) President Ryan S. Napierski sold 10,000 shares of the firm’s stock in a transaction dated Friday, August 3rd. The stock was sold at an average price of $80.00, for a total value of $800,000.00. Following the sale, the president now directly owns 74,602 shares of the company’s stock, valued at $5,968,160. The transaction was disclosed in a document filed with the SEC, which is available through this link.

  • [By Joseph Griffin]

    Vident Investment Advisory LLC acquired a new stake in Nu Skin Enterprises, Inc. (NYSE:NUS) in the second quarter, according to the company in its most recent filing with the SEC. The firm acquired 4,458 shares of the company’s stock, valued at approximately $349,000.

  • [By Shane Hupp]

    Pivotal Research reaffirmed their buy rating on shares of Nu Skin Enterprises (NYSE:NUS) in a research report sent to investors on Wednesday morning. They currently have a $85.00 target price on the stock.

  • [By Max Byerly]

    Nu Skin Enterprises (NYSE: NUS) and PetIQ (NASDAQ:PETQ) are both consumer staples companies, but which is the better stock? We will contrast the two companies based on the strength of their institutional ownership, earnings, dividends, profitability, analyst recommendations, valuation and risk.

  • [By Shane Hupp]

    Get a free copy of the Zacks research report on Nu Skin Enterprises (NUS)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com